S12) Lung Cancer Flashcards

1
Q

Describe the incidence of lung cancer

A
  • Highest cancer related deaths world wide
  • 35,000 deaths per year – UK
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Identify 5 risk factors for lung cancer

A
  • Smoking
  • Asbestos
  • Radon (from mining or indoor exposure)
  • Other occupational carcinogens – chromium, nickel, arsenic
  • Genetic/familial factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the impact of smoking on lung cancer

A

Smoking causes:

  • ~90% of lung cancer deaths in men
  • ~80% of lung cancer deaths in women
  • ~20% of lung cancer cases in nonsmokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Identify five symptoms reported by patients with lung cancer at the primary tumour stage

A
  • Cough
  • Dyspnoea
  • Haemoptysis
  • Chest / shoulder pain
  • Weight Loss

Some are asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Identify and describe five symptoms reported by patients with lung cancer at the regional metastases stage

A
  • Bloated face – SVC obstruction
  • Hoarseness – left recurrent laryngeal nerve palsy
  • Dyspnoea – anaemia, pleural or pericardial effusions
  • Dysphagia – oesophageal compression
  • Chest pain – parietal pleural involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Identify two symptoms reported by patients with lung cancer at the distant metastases stage

A
  • Bone pain/fractures
  • CNS symptoms (headache, double vision, confusion etc.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Identify three metabolic symptoms reported by patients with lung cancer

A
  • Thirst (hypercalcaemia)
  • Constipation (hypercalcaemia)
  • Seizures (hyponatraemia – SIADH, small cell)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Identify six signs associated with lung cancer

A
  • Cachexia
  • Cervical lymphadenopathy
  • Horners Syndrome
  • Consolidation
  • Finger clubbing (due to reduced oxygen)
  • SVC obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the associated clinical features of superior vena cava obstruction?

A
  • Blushing of face
  • Decreased CO (venous return)
  • Visible vein
  • Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Identify and describe some paraneoplastic syndromes accompanied with lung cancer involving the following systems:

  • Endocrine
  • CNS
  • Haematological
  • Cutaneous
  • MSK
A
  • Endocrine: hypercalcaemia, Cushing’s syndrome, SIADH
  • Neurological: encephalopathy, Horner’s syndrome
  • Haematological: anaemia, thrombocytosis
  • Cutaneous: dermatomyositis
  • Skeletal: finger clubbing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which staging technique is used to classify lung cancer?

A

TNM staging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which two staging tests are used for lung cancer?

A
  • Imaging
  • Tissue sampling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which imaging techniques are used in the diagnosis and treatment of lung cancer?

A
  • All: CT scan, CXR
  • Some: PET scan, MRI, bone scan, ultrasound, echocardiogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Identify five common methods used to obtain material for histological diagnosis in lung cancer

A
  • Bronchoscopy – standard or with endobronchial ultrasound (EBUS)
  • Cervical lymph node fine needle aspiration (FNA)
  • Pleural fluid aspiration (thorocentesis)
  • CT biopsy – lung/pleura
  • Thoracoscopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Identify the five different histological types of lung cancer

A
  • Non-small cell lung cancer:

I. Squamous cell carcinoma ~40%

II. Adenocarcinoma ~35%

III. Large cell carcinoma ~5%

  • Small cell carcinoma ~ 12%
  • Rare tumours e.g. carcinoid ~5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the histological appearance a NSCLC adenocarcinoma

A
17
Q

Describe the histological appearance a squamous cell lung cancer

A
18
Q

Describe the histological appearance a large cell carcinoma

A
19
Q

Describe the histological appearance a small cell carcinoma

A
20
Q

Distinguish between NSCLC and SCLC in terms of:

  • Origin
  • Classification
  • Metastatic potential
  • Treatment
  • 5 year survival
A
21
Q

Identify the five molecular markers for lung cancer

A
  • EGFR mutations
  • ALK mutation
  • KRAS mutations
  • PD1 mutations
  • PDL1 mutations
22
Q

Which local and distant structures can lung cancer metastasise to?

A
23
Q

List the different possible treatment options for lung cancer

A
  • Surgery
  • Radiotherapy
  • Combination chemotherapy
  • Combination therapy
  • ‘Biological’ (‘Targeted’) therapies
  • Palliative Care & other treatment
24
Q

Outline surgery as a treatment option for lung cancer

A
  • Mostly for NSCLC (20-25% operable)
  • The best chance of cure
25
Q

Outline radiotherapy as a treatment option for lung cancer

A
  • Radical – with curative intent
  • Palliative – symptom control
26
Q

Outline combination chemotherapy as a treatment option for lung cancer

A
  • SCLC – potentially curative in a minority
  • NSCLC – modest survival increase, symptom control
27
Q

Identify and describe the two different types of combine chemotherapy

A
  • Neoadjuvant therapy – chemo before surgery to downstage the tumour
  • Adjuvant therapy – chemo after surgery (no benefit if < stage 2)
28
Q

Outline combination therapy as a treatment option for lung cancer

A

Combination chemo-radiotherapy is potentially curative

29
Q

Outline the use of biological / targeted therapies in the treatment of lung cancer

A
  • A potential ‘gamechanger’
  • Based on mutational analysis (EGFR, ALK, RAS, PD1, PDL1)
30
Q

Outline the use of palliative care and other treatments in the treatment of lung cancer

A
  • Active symptom control e.g. analgesia, radiotherapy, airway stents, nutritional support, patient support groups
  • Treatment of tobacco addiction, coronary heart disease & other conditions